In colorectal cancer, the absence of EP300 inhibits the enzyme activity of ENO1 by reducing the level of lysine 2‐hydroxyisobutyrylation (Khib) on ENO1, thereby affecting glycolysis.28 This evidence concerns the gene ENO1 and colorectal cancer.